<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e>) is one of the most common (1:3000-1:4000) <z:e sem="disease" ids="C0410787" disease_type="Disease or Syndrome" abbrv="">heritable connective tissue disorders</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>It's still a rarely diagnosed syndrome, especially in childhood </plain></SENT>
<SENT sid="2" pm="."><plain>Near <z:hpo ids='HP_0000001'>all</z:hpo> cases <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> results from mutations in the fibrillin-1 (FBN1) gene on chromosome 15q21.1, which encodes for the <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> fibrillin </plain></SENT>
<SENT sid="3" pm="."><plain>The FBN1 gene is a large protein that can cause more than 500 mutations and molecular examinations, finally confirming the diagnosis, are conducted extremely rare </plain></SENT>
<SENT sid="4" pm="."><plain>We present prospective data concerning 66 patients with clinically-diagnosed <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> who have been controlled in Department of Pediatric Cardiology and <z:hpo ids='HP_0002564'>Congenital Heart Diseases</z:hpo> Medical University in Gdansk in 2000 - 2010 </plain></SENT>
<SENT sid="5" pm="."><plain>29 patients (44%) had <z:hpo ids='HP_0001653'>mitral valve regurgitations</z:hpo>, 19 (29%) aneurysmal <z:mpath ids='MPATH_66'>dilatation</z:mpath> of the aorta, 13 (20%) had both these irregularities </plain></SENT>
<SENT sid="6" pm="."><plain>In 7 cases (11%) diagnosis of <z:hpo ids='HP_0001634'>mitral valve prolapse</z:hpo> preceded appearance of an aneurysmal dilalation of the aortic bulb </plain></SENT>
<SENT sid="7" pm="."><plain>During the observation 11 patients (17%) underwent cardiosurgical procedures for the sake of stopping crucial progressive mitral valve dysfunction and/or aneurysmal <z:mpath ids='MPATH_66'>dilatation</z:mpath> of the aortic bulb, which threatened with a rupture of <z:hpo ids='HP_0004942'>aortic aneurysm</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>In 39 cases (59%) prophylactic treatment with beta - blockers was administered </plain></SENT>
<SENT sid="9" pm="."><plain>The patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> need a multidisciplinary system of care and the psychological supporting </plain></SENT>
<SENT sid="10" pm="."><plain>The cardiosurgical treatment, which nowadays is bringing better results, due to the technological advancements is a new hope for this patient population </plain></SENT>
</text></document>